Survivin protects fused cancer cells from cell death

BMB Rep. 2017 Jul;50(7):361-366. doi: 10.5483/bmbrep.2017.50.7.185.

Abstract

Tetraploidy, a potential precursor of cancer-associated aneuploidy, is produced either by cell fusion or failure of cytokinesis. In this study, low p53-expressing HeLa cells were used to address the fate of cancer cells after fusion. We found that massive cell death or growth arrest occurred a few days after fusion. Interestingly, cells with larger nuclei preferentially died after fusion, suggesting that a larger deviation of DNA content is a strong inducer of apoptosis. Notably, a fraction of cells escaped cell death. Also, the stability of survivin increased, and its localization changed preferentially to the cytosol in fused cells. Knockdown of survivin decreased the survival of fused cells, more than observed in unfused cells, showing increased dependency of fused cells on survivin. Collectively, after cancer cell fusion, some fused cells avoid the apoptotic crisis partly owing to survivin, and continue to proliferate, a process that contributes to human cancer progression. [BMB Reports 2017; 50(7): 361-366].

Publication types

  • News

MeSH terms

  • Cell Death
  • Cell Proliferation
  • Female
  • HeLa Cells
  • Humans
  • Inhibitor of Apoptosis Proteins / metabolism*
  • Survivin
  • Uterine Cervical Neoplasms / metabolism*
  • Uterine Cervical Neoplasms / pathology*

Substances

  • BIRC5 protein, human
  • Inhibitor of Apoptosis Proteins
  • Survivin